CORE--MOLECULAR BIOLOGY/BIOMARKER LABORATORY

$117,868P30FY2000ESNIH

University Of Washington, Seattle WA

Investigators

Linked publications & trials

Paper 39492664 Paper 39463992 Paper 39463434 Paper 39363503 Paper 39352804 Paper 39314929 Paper 39285150 Paper 39229214 Paper 39105659 Paper 39080971 Paper 39072047 Paper 39036466 Paper 38986717 Paper 38982119 Paper 38964581 Paper 38959439 Paper 38941464 Paper 38915703 Paper 38871635 Paper 38863574 Paper 38853984 Paper 38843171 Paper 38765981 Paper 38746422 Paper 38734683 Paper 38730039 Paper 38728283 Paper 38648751 Paper 38636274 Paper 38600956 Paper 38598326 Paper 38579196 Paper 38552894 Paper 38536883 Paper 38534032 Paper 38507607 Paper 38498466 Paper 38485845 Paper 38485010 Paper 38460460 Paper 38454435 Paper 38423310 Paper 38415616 Paper 38410758 Paper 38408408 Paper 38399338 Paper 38352056 Paper 38349877 Paper 38346713 Paper 38343741 Paper 38331928 Paper 38330074 Paper 38307853 Paper 38275332 Paper 38226871 Paper 38213500 Paper 38212375 Paper 38199129 Paper 38194756 Paper 38185046 Paper 38176057 Paper 38175185 Paper 38153877 Paper 38153213 Paper 38147948 Paper 38122928 Paper 38091568 Paper 38045485 Paper 38045361 Paper 38012123 Paper 37994374 Paper 37987098 Paper 37967704 Paper 37856832 Paper 37728927 Paper 37691174 Paper 37665647 Paper 37581863 Paper 37578757 Paper 37503063 Paper 37466697 Paper 37425094 Paper 37398080 Paper 37397146 Paper 37394870 Paper 37389972 Paper 37362398 Paper 37331181 Paper 37326985 Paper 37304341 Paper 37298071 Paper 37268414 Paper 37267213 Paper 37263750 Paper 37216796 Paper 37210597 Paper 37164652 Paper 37157132 Paper 37146269 Paper 37124288

Abstract

Description: The overall objective of this Core is to provide state-of-the- art capabilities for identifying and characterizing genetic associations to environmentally initiated disease. The core identified three aims that focus on the development of instrumentation for multi-user access to high throughput DNA sequencing and automated genotyping servicing, provision of consultation on the adaptation of molecular approaches to individual research programs, and integration of functional genomics capabilities (real-time quantitative PCR and DNA chip expression array technologies).

View original record on NIH RePORTER →